» Authors » David de la Rosa

David de la Rosa

Explore the profile of David de la Rosa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 556
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Oscullo G, Bekki A, Olveira C, Giron R, Garcia-Clemente M, Maiz L, et al.
Arch Bronconeumol . 2025 Feb; PMID: 39956702
Introduction: Blood eosinophil counts (BEC) have been related to the severity of bronchiectasis and its response to inhaled corticosteroids. However, only the baseline BEC has been used to assess this...
2.
Garin N, Zarate-Tamames B, Lertxundi U, Martin da Silva I, Orive G, Crespo-Lessmann A, et al.
Eur J Hosp Pharm . 2025 Jan; PMID: 39788701
Background: The healthcare sector contributes significantly to global greenhouse emissions, with inhalers being major contributors. Objective: To develop a framework for reducing the environmental footprint of inhalers in Spain by...
3.
Martinez-Garcia M, Oscullo G, Gomez-Olivas J, Olveira C, Giron R, Garcia-Clemente M, et al.
Arch Bronconeumol . 2023 Aug; 59(10):688-690. PMID: 37563019
No abstract available.
4.
Cendon L, Rafecas Codern A, de la Rosa D, Castellvi I, Spagnolo P, Castillo D
Open Respir Arch . 2023 Jul; 4(4):100211. PMID: 37496960
Introduction: Regardless corticosteroids are recommended for the treatment of organizing pneumonia there is limited evidence supporting this practice. Thus, we performed a systematic review of the literature on systemic corticosteroid...
5.
Martinez-Garcia M, Mendez R, Olveira C, Giron R, Garcia-Clemente M, Maiz L, et al.
Chest . 2023 Apr; 164(3):606-613. PMID: 37088355
Background: Although a proven relationship exists between the blood eosinophil count (BEC) and the severity of both asthma and COPD, its relationship with bronchiectasis has not been well established. The...
6.
Oscullo G, de la Rosa D, Clemente M, Giron R, Golpe R, Maiz L, et al.
Expert Rev Respir Med . 2023 Apr; 17(4):279-293. PMID: 37077039
Introduction: Bronchiectasis is a very heterogeneous disease. This heterogeneity has several consequences: severity cannot be measured by a single variable, so multidimensional scores have been developed to capture it more...
7.
Menendez R, Mendez R, Latorre A, Gonzalez-Jimenez P, Peces-Barba G, Molina M, et al.
J Intern Med . 2023 Apr; 294(1):69-82. PMID: 37038609
Introduction: After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, patients may show lung sequelae on radiology and functional impairment at the 1-year follow-up. We aimed to describe the persistence...
8.
Martinez-Garcia M, Olveira C, Giron R, Garcia-Clemente M, Maiz-Carro L, Sibila O, et al.
Biomolecules . 2022 Oct; 12(10). PMID: 36291608
Most patients with bronchiectasis have a predominantly neutrophilic inflammatory profile, although other cells such as lymphocytes (as controllers of bronchial inflammation) and eosinophils also play a significant pathophysiological role. Easy-to-interpret...
9.
Solarat B, Perea L, Faner R, de la Rosa D, Martinez-Garcia M, Sibila O
Arch Bronconeumol . 2022 Sep; 59(2):101-108. PMID: 36180278
Bronchiectasis is a complex and heterogeneous disease. Its pathophysiology is poorly understood, but chronic bronchial infection plays an important role in its natural history, and is associated with poor quality...
10.
Clemente M, Olveira C, Giron R, Maiz L, Sibila O, Golpe R, et al.
J Clin Med . 2022 Jul; 11(14). PMID: 35887723
The objective of the study was to analyze the factors associated with chronic bronchial infection (CBI) due to methicillin-susceptible Staphylococcus aureus (SA) and assess the clinical impact on severity, exacerbations,...